Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. (Q55474952)
Jump to navigation
Jump to search
scientific article published in November 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. |
scientific article published in November 2000 |
Statements
1 reference
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. (English)
1 reference
H S Friedman
1 reference
D D Bigner
1 reference
R E Coleman
1 reference
I Cokgor
1 reference
G Akabani
1 reference
C T Kuan
1 reference
A H Friedman
1 reference
R E McLendon
1 reference
S H Bigner
1 reference
X G Zhao
1 reference
A M Garcia-Turner
1 reference
C N Pegram
1 reference
C J Wikstrand
1 reference
T D Shafman
1 reference
J E Herndon
1 reference
J M Provenzale
1 reference
M R Zalutsky
1 reference
1 November 2000
1 reference
18
1 reference
3862-3872
1 reference
22
1 reference
Identifiers
1 reference